Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1080-1088

  Feng, Yin Hsun ^a,b   Lin, Cheng Yao ^b   Huang, Wen Tsung ^b   Wu, Chia Ling ^b   Fang, Jui Lung ^b   Tsao, Chao Jung ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Diabetes mellitus; Hepatocellular carcinoma; Insulin; Intra arterial chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; GLUCOSE; INSULIN; SORAFENIB;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CELL PROLIFERATION; CELL STRAIN HEPG2; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; INOPERABLE CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84655176767     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9650-9     Document Type: Article

References (39)

1. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 9 533 543
2. Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009.
3. HE Blum 2005 Hepatocellular carcinoma: therapy and prevention World J Gastroenterol 11 47 7391 7400
4. H Hung 2005 Treatment modalities for hepatocellular carcinoma Curr Cancer Drug Targets 5 2 131 138
5. T Yau P Chan R Epstein RT Poon 2008 Evolution of systemic therapy of advanced hepatocellular carcinoma World J Gastroenterol 14 42 6437 6441
6. EC Lai 1990 Doxorubicin for unresectable hepatocellular carcinoma. A prospective study on the addition of verapamil Cancer 66 8 1685 1687
7. AX Zhu 2006 Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? Oncologist 11 7 790 800
8. C Breedis G Young 1954 The blood supply of neoplasms in the liver Am J Pathol 30 5 969 977
9. K Murata 2003 Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unrespectable hepatocellular carcinoma Anticancer Res 23 2C 1719 1722
10. E Ando 2002 Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases Cancer 95 3 588 595
11. H Tanioka 2003 Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma Anticancer Res 23 2C 1891 1897
12. ME Kingston MA Ali M Atiyeh RJ Donnelly 1984 Diabetes mellitus in chronic active hepatitis and cirrhosis Gastroenterology 87 3 688 694
13. C La Vecchia E Negri A Decarli S Franceschi 1997 Diabetes mellitus and the risk of primary liver cancer Int J Cancer 73 2 204 207
14. J Tazawa 2002 Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C Dig Dis Sci 47 4 710 715
15. MS Lai MS Hsieh YH Chiu TH Chen 2006 Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection Hepatology 43 6 1295 1302
16. AS Caudle 2008 Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer Ann Surg Oncol 15 7 1931 1936
17. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20(7):1183-1197.
18. P Therasse 2000 New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada J Natl Cancer Inst 92 3 205 216
19. KH Link 1998 In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols Semin Surg Oncol 14 3 189 201
20. JM Llovet 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 4 378 390
21. K Sakai DR Clemmons 2003 Glucosamine induces resistance to insulin-like growth factor I (IGF-I) and insulin in Hep G2 cell cultures: biological significance of IGF-I/insulin hybrid receptors Endocrinology 144 6 2388 2395
22. A Miglietta 2004 Insulin can modulate MCF-7 cell response to paclitaxel Cancer Lett 209 2 139 145
23. A Sasaki 1994 Mortality and causes of death in patients with diabetes mellitus in Japan Diabetes Res Clin Pract 24 Suppl S299 S306
24. HO Adami 1996 Excess risk of primary liver cancer in patients with diabetes mellitus J Natl Cancer Inst 88 20 1472 1477
25. MM Hassan 2002 Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 5 1206 1213
26. CL Chen 2008 Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan Gastroenterology 135 1 111 121
27. T Komura 2007 Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis Am J Gastroenterol 102 9 1939 1946
28. Y Kawamura 2008 Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis J Gastroenterol Hepatol 23 11 1739 1746
29. AL Cheng 2009 Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 1 25 34
30. T Yamasaki 2005 Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy J Gastroenterol 40 1 70 78
31. DL White V Ratziu HB El-Serag 2008 Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis J Hepatol 49 5 831 844
32. K Moriya 1998 The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat Med 4 9 1065 1067
33. M Yoneda 2007 Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients J Viral Hepat 14 9 600 607
34. XZ Ding 2000 Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression Pancreas 21 3 310 320
35. WE Fisher LG Boros WJ Schirmer 1995 Reversal of enhanced pancreatic cancer growth in diabetes by insulin Surgery 118 2 453 457 (discussion 7-8)
36. K Breuhahn T Longerich P Schirmacher 2006 Dysregulation of growth factor signaling in human hepatocellular carcinoma Oncogene 25 27 3787 3800
37. XX Fu 1988 Insulin like growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers J Virol 62 9 3422 3430
38. Li D, et al. Anti-diabetic therapies affect risk of pancreatic cancer. Gastroenterology. 2009.
39. L Takiya S Chawla 2002 Therapeutic options for the management of type 2 diabetes mellitus Am J Manag Care 8 11 1009 1023 (quiz 24-7)